SFI
ATRC icon

Susquehanna Fundamental Investments’s AtriCure ATRC Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-75,922
Closed -$2.68M – 567
2025
Q3 		$2.68M Sell
75,922
-16,714
-18% -$576K 0.1% 206
2025
Q2 		$3.04M Sell
92,636
-17,705
-16% -$575K 0.08% 267
2025
Q1 		$3.56M Buy
110,341
+6,247
+6% +$232K 0.05% 392
2024
Q4 		$3.18M Buy
+104,094
New +$3.35M 0.05% 424

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Susquehanna Fundamental Investments's ATRC Position: Q4 2025 in Review

Susquehanna Fundamental Investments sold out of AtriCure (ATRC) in Q4 2025, closing a stake of 75,922 shares — an estimated $2.68M sold.

Susquehanna Fundamental Investments first reported a position in ATRC in Q4 2024 and held it in 4 quarters. The position peaked at $3.56M in Q1 2025. 234 funds tracked by Wall St. Rank hold ATRC as of Q4 2025.

  • Susquehanna Fundamental Investments reported no remaining AtriCure position as of Q4 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 75,922 AtriCure shares in Q4 2025, an estimated $2.68M.
  • Susquehanna Fundamental Investments first reported a position in AtriCure in Q4 2024 and held it in 4 quarters.
  • Susquehanna Fundamental Investments's AtriCure position peaked at $3.56M in Q1 2025.
  • 234 funds tracked by Wall St. Rank held AtriCure as of Q4 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2025, filed 17 Feb 2026.